| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1091344466 |
| P356 | DOI | 10.1038/S41598-017-07442-Y |
| P932 | PMC publication ID | 5577282 |
| P698 | PubMed publication ID | 28855526 |
| P2093 | author name string | Xue Zhang | |
| Wen Zhang | |||
| Guanhua Du | |||
| Yulin Yang | |||
| Lida Du | |||
| Qimeng Zhou | |||
| P2860 | cites work | Baicalein inhibits α-synuclein oligomer formation and prevents progression of α-synuclein accumulation in a rotenone mouse model of Parkinson's disease | Q57104189 |
| Objective clinical assessment of motor function after experimental spinal cord injury in the rat | Q67676648 | ||
| Mitochondrial complex I deficiency in Parkinson's disease | Q69370277 | ||
| Involvement of nitric oxide in noradrenaline-induced increase in blood flow through brown adipose tissue | Q72642770 | ||
| The D2 autoreceptor agonists SND 919 and PD 128483 decrease stereotypy in developing rats | Q72659989 | ||
| Modeling clinical features of neurodegeneration | Q82769616 | ||
| Baicalein protects the brain against neuron impairments induced by MPTP in C57BL/6 mice | Q83285673 | ||
| Constitutive SIRT1 overexpression impairs mitochondria and reduces cardiac function in mice | Q85028210 | ||
| Neurobehavioral assessment of outcome following traumatic brain injury in rats: an evaluation of selected measures | Q44884816 | ||
| ERK and p38 inhibitors attenuate memory deficits and increase CREB phosphorylation and PGC-1α levels in Aβ-injected rats | Q45702362 | ||
| Acetyl-L-carnitine-mediated neuroprotection during hypoxia is attributed to ERK1/2-Nrf2-regulated mitochondrial biosynthesis | Q46087901 | ||
| Exercise with low glycogen increases PGC-1α gene expression in human skeletal muscle | Q46311179 | ||
| Neuroprotective effect of baicalein against MPTP neurotoxicity: behavioral, biochemical and immunohistochemical profile | Q46513468 | ||
| The Interaction of Mitochondrial Biogenesis and Fission/Fusion Mediated by PGC-1α Regulates Rotenone-Induced Dopaminergic Neurotoxicity | Q46536429 | ||
| Mitochondrial dynamics and mitophagy in Parkinson's disease: A fly point of view | Q46642004 | ||
| Mitochondrial complex I, II/III, and IV activities in familial and sporadic Parkinson's disease | Q47820662 | ||
| Prevention of vascular smooth muscle cell proliferation and injury-induced neointimal hyperplasia by CREB-mediated p21 induction: An insight from a plant polyphenol | Q47886710 | ||
| Protective effects of baicalein against rotenone-induced neurotoxicity in PC12 cells and isolated rat brain mitochondria | Q48842987 | ||
| Assessment of the treatment effect of baicalein on a model of Parkinsonian tremor and elucidation of the mechanism | Q50259411 | ||
| Carvedilol promotes mitochondrial biogenesis by regulating the PGC-1/TFAM pathway in human umbilical vein endothelial cells (HUVECs). | Q50267197 | ||
| Activation of AMP-activated protein kinase by metformin protects against global cerebral ischemia in male rats: interference of AMPK/PGC-1α pathway. | Q54383877 | ||
| Mitochondrial defect and PGC-1α dysfunction in parkin-associated familial Parkinson's disease. | Q54393752 | ||
| Baicalein protects against 6-OHDA-induced neurotoxicity through activation of Keap1/Nrf2/HO-1 and involving PKCα and PI3K/AKT signaling pathways. | Q54494363 | ||
| Mitochondria: A Therapeutic Target for Parkinson's Disease? | Q26784216 | ||
| Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1 | Q28131760 | ||
| SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha} | Q28235481 | ||
| CREB regulates hepatic gluconeogenesis through the coactivator PGC-1 | Q29615692 | ||
| AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha | Q29620443 | ||
| Disease and the brain's dark energy | Q33522559 | ||
| Mitochondrial enzymes and endoplasmic reticulum calcium stores as targets of oxidative stress in neurodegenerative diseases | Q35891872 | ||
| Cognitive impairment and dementia in Parkinson's disease: clinical features, diagnosis, and management. | Q35988441 | ||
| Mitochondrial biogenesis: a therapeutic target for neurodevelopmental disorders and neurodegenerative diseases | Q36771650 | ||
| Structural characteristics of alpha-synuclein oligomers stabilized by the flavonoid baicalein | Q36950121 | ||
| PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure | Q37412140 | ||
| Mitochondrial quality control and neurological disease: an emerging connection | Q37732485 | ||
| Mitochondrial dynamics and neuronal fate in Parkinson's disease. | Q38011533 | ||
| The interplay of neuronal mitochondrial dynamics and bioenergetics: implications for Parkinson's disease | Q38016276 | ||
| An update on the rotenone models of Parkinson's disease: their ability to reproduce the features of clinical disease and model gene-environment interactions. | Q38290588 | ||
| Peroxisome Proliferator Activated Receptor Gamma Coactivator 1 Alpha: An Emerging Target for Neuroprotection in Parkinson's Disease | Q38391039 | ||
| SIRT5 is under the control of PGC-1α and AMPK and is involved in regulation of mitochondrial energy metabolism | Q39009602 | ||
| Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment. | Q39016389 | ||
| Baicalein prevents 6-hydroxydopamine-induced mitochondrial dysfunction in SH-SY5Y cells via inhibition of mitochondrial oxidation and up-regulation of DJ-1 protein expression. | Q39052298 | ||
| Mitochondrial biogenesis in neurodegeneration | Q39181903 | ||
| Differential effects of wild-type and A53T mutant isoform of alpha-synuclein on the mitochondrial proteome of differentiated SH-SY5Y cells | Q39723568 | ||
| Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro | Q39867380 | ||
| p38 mitogen-activated protein kinase activates peroxisome proliferator-activated receptor alpha: a potential role in the cardiac metabolic stress response | Q40778028 | ||
| Mitochondrial complex I deficiency in Parkinson's disease. | Q40868964 | ||
| The Protective Effects of Salidroside from Exhaustive Exercise-Induced Heart Injury by Enhancing the PGC-1 α -NRF1/NRF2 Pathway and Mitochondrial Respiratory Function in Rats | Q41523477 | ||
| Exercise-induced metabolic fluctuations influence AMPK, p38-MAPK and CaMKII phosphorylation in human skeletal muscle | Q41881893 | ||
| Excessive levels of nitric oxide in rat model of Parkinson's disease induced by rotenone | Q42083792 | ||
| The rotenone-induced rat model of Parkinson's disease: behavioral and electrophysiological findings | Q42469262 | ||
| Baicalein attenuates astroglial activation in the 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine-induced Parkinson's disease model by downregulating the activations of nuclear factor-κB, ERK, and JNK. | Q43730264 | ||
| The flavonoid baicalein inhibits fibrillation of alpha-synuclein and disaggregates existing fibrils | Q44851129 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 9968 | |
| P577 | publication date | 2017-08-30 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Therapeutic effects of baicalein on rotenone-induced Parkinson's disease through protecting mitochondrial function and biogenesis | |
| P478 | volume | 7 |
| Q60046539 | A comprehensive review on phytochemistry, pharmacology, and flavonoid biosynthesis of Scutellaria baicalensis |
| Q55405917 | Flavonoids as Therapeutic Agents in Alzheimer's and Parkinson's Diseases: A Systematic Review of Preclinical Evidences. |
| Q47251476 | Multi-Protection of DL0410 in Ameliorating Cognitive Defects in D-Galactose Induced Aging Mice |
| Q90361871 | Potential Antidepressant Effects of Scutellaria baicalensis, Hericium erinaceus and Rhodiola rosea |
| Q92991007 | The Potential of Flavonoids for the Treatment of Neurodegenerative Diseases |
Search more.